← Back to Search

Spoken Language Analysis for Bipolar Disorder

N/A

Recruiting

Led By Mark Frye, MD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Undergoing hospitalization, or boarding in the Emergency Department, for mania as determined by primary clinical staff

Documented clinical diagnosis for Bipolar I Disorder

Must not have

Individuals who have a guardian and are unable to consent for themselves

Current communicable disease requiring isolation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up approximately 48 hours after taking antimanic medications until up to end of subject participation approximately 1 month from enrollment

Awards & highlights

No Placebo-Only Group

Summary

This trial looks into how mania affects voice and speech: results may help improve care for people with bipolar disorder.

Who is the study for?

This study is for English-speaking individuals with a confirmed diagnosis of Bipolar I Disorder who are currently hospitalized or in the Emergency Department due to mania. Participants must be able to give informed consent and understand the study's objectives. Those with drug use, paranoia about electronic surveillance, developmental delays, involuntary hospitalization, communicable diseases requiring isolation, or risk of aggression cannot join.

What is being tested?

The trial aims to investigate changes in voice and speech patterns during manic episodes by conducting research interviews with participants experiencing mania as part of their bipolar disorder.

What are the potential side effects?

Since this trial involves research interviews rather than medication or medical procedures, there are no direct physical side effects expected from participating. However, discussing personal experiences during an interview may cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently hospitalized or in the ER for mania as determined by my doctor.

Select...

I have been diagnosed with Bipolar I Disorder.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a guardian and cannot make medical decisions on my own.

Select...

I have a contagious disease that requires me to be isolated.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ approximately 48 hours after taking antimanic medications until up to end of subject participation approximately 1 month from enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~approximately 48 hours after taking antimanic medications until up to end of subject participation approximately 1 month from enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 48 hours after taking antimanic medications until up to end of subject participation approximately 1 month from enrollment for reporting.